Ladenburg Thalmann Financial Services’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-14
| Closed | – | – | 5544 |
|
|
2018
Q4 | $0 | Buy |
14
+5
| +56% | +$3 | ﹤0.01% | 5549 |
|
|
2018
Q3 | $0 | Sell |
9
-5
| -36% | -$8 | ﹤0.01% | 5568 |
|
|
2018
Q2 | $0 | Hold |
14
| – | – | ﹤0.01% | 5233 |
|
|
2018
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 5360 |
|
|
2017
Q4 | $0 | Hold |
14
| – | – | ﹤0.01% | 5277 |
|
|
2017
Q3 | $0 | Buy |
14
+5
| +56% | +$16 | ﹤0.01% | 5194 |
|
|
2017
Q2 | $0 | Hold |
9
| – | – | ﹤0.01% | 5137 |
|
|
2017
Q1 | $0 | Hold |
9
| – | – | ﹤0.01% | 5141 |
|
|
2016
Q4 | $0 | Buy |
9
+4
| +80% | +$14 | ﹤0.01% | 5109 |
|
|
2016
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 4989 |
|
|
2016
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 4967 |
|
|
2016
Q1 | $0 | Sell |
5
-16
| -76% | -$318 | ﹤0.01% | 4960 |
|
|
2015
Q4 | $1K | Sell |
21
-164
| -89% | -$4.96K | ﹤0.01% | 4623 |
|
|
2015
Q3 | $6K | Sell |
185
-380
| -67% | -$18.2K | ﹤0.01% | 3889 |
|
|
2015
Q2 | $33K | Buy |
565
+380
| +205% | +$26.8K | ﹤0.01% | 2889 |
|
|
2015
Q1 | $20K | Sell |
185
-77
| -29% | -$7.34K | ﹤0.01% | 3194 |
|
|
2014
Q4 | $24K | Buy |
262
+251
| +2,282% | +$23.9K | ﹤0.01% | 2886 |
|
|
2014
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 3869 |
|
|
2014
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 3836 |
|
|
2014
Q1 | $1K | Buy |
+11
| New | +$363 | ﹤0.01% | 3690 |
|
Ladenburg Thalmann Financial Services's PTX Position: Q1 2019 in Review
Ladenburg Thalmann Financial Services sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 14 shares.
Ladenburg Thalmann Financial Services first reported a position in PTX in Q1 2014 and held it in 20 quarters. The position peaked at $33K in Q2 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Ladenburg Thalmann Financial Services reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Ladenburg Thalmann Financial Services sold 14 Pernix Therapeutics Holdings, Inc. shares in Q1 2019.
- Ladenburg Thalmann Financial Services first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 20 quarters.
- Ladenburg Thalmann Financial Services's Pernix Therapeutics Holdings, Inc. position peaked at $33K in Q2 2015.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2019, filed 15 May 2019.